Detalles de la búsqueda
1.
Biological/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a multicenter prospective observational study.
Rheumatology (Oxford)
; 2023 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37934120
2.
Systematic review and meta-analysis for 2023 clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of ANCA-associated vasculitis.
Mod Rheumatol
; 33(5): 982-989, 2023 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-36112482
3.
T helper cells expressing fractalkine receptor and bearing T follicular helper 1-like cell functions in patients with IgG4-related disease.
Rheumatology (Oxford)
; 61(9): 3854-3863, 2022 08 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34940835
4.
Efficacy and safety of belimumab during maintenance therapy in patients with systemic lupus erythematosus.
Rheumatology (Oxford)
; 61(9): 3614-3626, 2022 08 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34962998
5.
Efficacy and safety of tofacitinib versus baricitinib in patients with rheumatoid arthritis in real clinical practice: analyses with propensity score-based inverse probability of treatment weighting.
Ann Rheum Dis
; 80(9): 1130-1136, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33827788
6.
2019 Diagnostic criteria for mixed connective tissue disease (MCTD): From the Japan research committee of the ministry of health, labor, and welfare for systemic autoimmune diseases.
Mod Rheumatol
; 31(1): 29-33, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31903831
7.
An elderly man with mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) without neuropsychiatric sequelae.
Clin Case Rep
; 11(5): e7219, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37151945
8.
Sustained remission following the discontinuation of tofacitinib in patients with rheumatoid arthritis (XANADU study): an open-label randomised study.
RMD Open
; 9(2)2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37185309
9.
Precision medicine based on the phenotypic differences in peripheral T helper cells in patients with psoriatic arthritis: One year follow-up outcomes.
Front Med (Lausanne)
; 9: 934937, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35966881
10.
Impact of serum interleukin-22 as a biomarker for the differential use of molecular targeted drugs in psoriatic arthritis: a retrospective study.
Arthritis Res Ther
; 24(1): 86, 2022 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35428323
11.
Stimulator of Interferon Genes-associated Vasculopathy with an Onset in Infancy Diagnosed after the Development of Atypical Pulmonary Lesions During Treatment as Juvenile Idiopathic Arthritis.
Intern Med
; 60(7): 1109-1114, 2021 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33162473
12.
Conversion of T Follicular Helper Cells to T Follicular Regulatory Cells by Interleukin-2 Through Transcriptional Regulation in Systemic Lupus Erythematosus.
Arthritis Rheumatol
; 73(1): 132-142, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32720470
13.
The additive effects of hydroxychloroquine to maintenance therapy with standard of care in patients with systemic lupus erythematosus.
Int J Rheum Dis
; 23(4): 549-558, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32020727
14.
Effectiveness and safety of hydroxychloroquine therapy with or without corticosteroid in patients with systemic lupus erythematosus.
Int J Rheum Dis
; 22(3): 434-442, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30338639
Resultados
1 -
14
de 14
1
Próxima >
>>